| Literature DB >> 28744486 |
Katy J Califf1, Karen Schwarzberg-Lipson1, Neha Garg2, Sean M Gibbons3, J Gregory Caporaso1, Jørgen Slots4, Chloe Cohen4, Pieter C Dorrestein2,5, Scott T Kelley6.
Abstract
Periodontitis is a polymicrobial infectious disease that causes breakdown of the periodontal ligament and alveolar bone. We employed a meta-omics approach that included microbial 16S rRNA amplicon sequencing, shotgun metagenomics, and tandem mass spectrometry to analyze sub- and supragingival biofilms in adults with chronic periodontitis pre- and posttreatment with 0.25% sodium hypochlorite. Microbial samples were collected with periodontal curettes from 3- to 12-mm-deep periodontal pockets at the baseline and at 2 weeks and 3 months. All data types showed high interpersonal variability, and there was a significant correlation between phylogenetic diversity and pocket depth at the baseline and a strong correlation (rho = 0.21; P = 0.008) between metabolite diversity and maximum pocket depth (MPD). Analysis of subgingival baseline samples (16S rRNA and shotgun metagenomics) found positive correlations between abundances of particular bacterial genera and MPD, including Porphyromonas, Treponema, Tannerella, and Desulfovibrio species and unknown taxon SHD-231. At 2 weeks posttreatment, we observed an almost complete turnover in the bacterial genera (16S rRNA) and species (shotgun metagenomics) correlated with MPD. Among the metabolites detected, the medians of the 20 most abundant metabolites were significantly correlated with MPD pre- and posttreatment. Finally, tests of periodontal biofilm community instability found markedly higher taxonomic instability in patients who did not improve posttreatment than in patients who did improve (UniFrac distances; t = -3.59; P = 0.002). Interestingly, the opposite pattern occurred in the metabolic profiles (Bray-Curtis; t = 2.42; P = 0.02). Our results suggested that multi-omics approaches, and metabolomics analysis in particular, could enhance treatment prediction and reveal patients most likely to improve posttreatment. IMPORTANCE Periodontal disease affects the majority of adults worldwide and has been linked to numerous systemic diseases. Despite decades of research, the reasons for the substantial differences among periodontitis patients in disease incidence, progressivity, and response to treatment remain poorly understood. While deep sequencing of oral bacterial communities has greatly expanded our comprehension of the microbial diversity of periodontal disease and identified associations with healthy and disease states, predicting treatment outcomes remains elusive. Our results suggest that combining multiple omics approaches enhances the ability to differentiate among disease states and determine differential effects of treatment, particularly with the addition of metabolomic information. Furthermore, multi-omics analysis of biofilm community instability indicated that these approaches provide new tools for investigating the ecological dynamics underlying the progressive periodontal disease process.Entities:
Keywords: 16S rRNA; diagnostics; metabolome; microbiome; molecular networking; periodontal disease; periodontitis; shotgun metagenomics
Year: 2017 PMID: 28744486 PMCID: PMC5513737 DOI: 10.1128/mSystems.00016-17
Source DB: PubMed Journal: mSystems ISSN: 2379-5077 Impact factor: 6.496
FIG 1 PCoA plots of subgingival samples with disease classification overlaid. Disease classifications: red, up to 6 mm; blue, >6 to 8 mm; orange, >8 mm. (A) 16S rRNA OTU-based weighted UniFrac distances (analysis of similarity, R = 0.015; P = 0.27); (B) Shotgun metagenomic species abundance-based Bray-Curtis distances (R = 0.006; P = 0.43); (C) Shotgun metagenomic pathway abundance-based Bray-Curtis distances (R = 0.204; P = 0.051).
Mantel test results for Pearson’s correlations between pairwise distance matrices for subgingival samples only
| Matrix | 16S rRNA genera (subgingival) | Shotgun species | Pathway abundance | Metabolites (subgingival) |
|---|---|---|---|---|
| 16S rRNA genera (subgingival) | — | 0.117, 0.067, 0.145 | 0.095, 0.473, 0.628 | 0.103, 0.039, 0.101 |
| Shotgun species | — | — | 0.299, 0.002, 0.009 | 0.016, 0.838, 0.838 |
| Pathway abundance | 17 | 17 | — | −0.048, 0.677, 0.8 |
| Metabolites (subgingival) | 124 | 17 | 17 | — |
The values above the blank diagonal are Mantel r statistics, P values, and q values (FDR-adjusted P values), in that order. The values below the diagonal are the numbers of entries.
—, not applicable.
Results of supervised classification of subgingival samples by using random forests
| 16S rRNA genus or ratio | Metabolites or ratio | Shotgun species or ratio |
|---|---|---|
| Disease class | ||
| 228.231–228.234_555–569 | ||
| Order ML615J-28 | 697.907–697.909_220–226 | TM7 |
| 872.632–872.634_222–227 | ||
| 453.356–453.359_701–706 | TM7 | |
| 705.697–705.703_220–226 | ||
| 689.111–689.113_218–222 | ||
| Family | 284.294–284.296_672–675 | |
| 257.246–257.249_225–227 | TM7 | |
| Family | 185.113–185.115_217–222 | |
| 698.306–698.308_221–227 | Order | |
| 1.5 | 1.61404 | 1.71429 |
| MPD | ||
| 480.546–480.554_525–581 | ||
| Family | 285.279–285.280_134–136 | |
| Order: ML615J-28 | 272.294–272.297_370–376 | |
| Family | 477.355–477.366_104–116 | |
| 497.357–497.366_765–803 | ||
| 382.156–382.159_330–362 | ||
| 611.354–611.358_462–473 | ||
| 285.277–285.280_149–177 | ||
| 497.083–497.091_349–367 | ||
| 475.096–475.105_713–757 | Family | |
| 1.25581 | 1.70175 | 0.89674 |
Shown are the top 10 features, as indicated by importance scores, predicting disease class (top) and MPD (bottom) from supervised classification analyses of subgingival samples.
Ratio of estimated generalization error to baseline error of the classifier for subgingival samples.
Not classifiable at a lower taxonomic level.
Summary of Spearman rank correlations for subgingival features correlated with MPD pre- and posttreatment
| Data set | No. of features correlated | ||
|---|---|---|---|
| Positively | Negatively | Significantly ( | |
| Pretreatment | |||
| 16S rRNA genera | 14 | 6 | 12 |
| Metagenomes (taxa) | 18 | 2 | 0 |
| Metagenomes (pathways) | 9 | 11 | 0 |
| Metabolites | 4 | 16 | 20 |
| Posttreatment | |||
| 16S rRNA genera | 12 | 8 | 11 |
| Metagenomes (taxa) | 6 | 14 | 0 |
| Metagenomes (pathways) | 7 | 13 | 0 |
| Metabolites | 17 | 4 | 20 |
The top 20 results for each feature are shown. Full results are shown in Table S4.
FIG 2 Molecular network analysis of UPLC-Q-TOF MS2 data. The networks were based on subgingival samples collected from the same periodontal pockets of 12 individuals before and after treatment. Individual MS2 features are highlighted on the basis of whether they were detected in samples collected before treatment, after treatment, or both. The Venn diagram indicates the numbers of features unique to before-treatment (blue) or after-treatment (purple) samples or common to both sets (orange).
FIG 3 CIS analysis. Bar graph illustrating changes in the microbiome composition of individuals who improved in measurable pocket depth (≥x mm) between time points with treatment and individuals who did not improve or got worse with treatment. The bars indicate the average UniFrac and Bray-Curtis distances between samples of the same periodontal pocket pretreatment and 2 weeks after treatment. Sample numbers are presented above the bars. t tests corrected for multiple comparisons were used to compare distances between categories for each data set: 16S rRNA OTU-based distances (weighted UniFrac), 16S rRNA genus-based distances (Bray-Curtis), and MS1 metabolite feature-based distances (Bray-Curtis).